NCT05633615 2026-02-02
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
SWOG Cancer Research Network
Phase 2 Recruiting
Clinical Trials
3 trialsNCT04778579 2024-06-26
CART19-BE-02
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Phase 2 Active not recruiting
NCT02030834 2023-06-22
Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas
University of Pennsylvania
Phase 2 Completed